基本信息
姓名: 杨柳 性别: 女
学历: 研究生 学位: 博士(硕导)
职称: 副主任医师 出生年份: 1978-10
博导类型: 博导专业: —— 博导学院: ——
硕导类型: 学术型/专业型 硕导专业: 肿瘤学 硕导学院: 第二临床医学院
Email: yangliuqq2003@163.com 联系电话:
研究方向: 长期从事恶性肿瘤的临床诊治及基础转化研究，在消化道肿瘤综合治疗、肿瘤基因组学、肿瘤免疫治疗新技术新药研发等方面开展深入系统研究。
工作单位: 浙江省人民医院
发表论文
1、Exome capture sequencing of adenoma reveals genetic alterations in multiple cellular pathways at the early stage of colorectal tumorigenesis,Yang L,Zheng S,PLoS One,SCI,2013-11,Zhejiang University School of Medicine,三区,2.766,e53310

---

2、Accumulating evidence: TLR signaling facilitates the development of hepatocellular carcinoma,Yang L,Dong Sheng Huang,Int J Clin Exp Med,SCI,2016-05,Zhejiang Provincial People’s Hospital,四区,0.181,4107-4112

---

3、Pharmacokinetics and safety of cyclophosphamide and docetaxel in hemodialysis patient with early stage breast cancer: a case report,Yang L,Shen P,BMC Cancer,SCI,2015-12,Zhejiang University School of Medicine,三区,2.933,917

---

4、A Novel WRN Frameshift Mutation Identified by Multiplex Genetic Testing in a Family with Multiple Cases of Cancer,Yang L,Zheng S,PLoS One,SCI,2015-04,Zhejiang University School of Medicine,三区,2.766,e**

---

5、Efficacy and Safety Profile of Celecoxib for Treating Advanced Cancers: A Meta- Analysis of 11 Randomized Clinical Trials,Chen J,Yang L,Clin Ther,SCI,2014-04,Zhejiang University School of Medicine,三区,2.935,1253-63

---

6、TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma,Song Ye,Yang L,ONCOLOGY REPORTS,SCI,2017-07,Zhejiang Provincial People’s Hospital,三区,2.976,2215-2226

---

7、Liquid Biopsy for Cancer: Circulating Tumor Cells, Circulating Free DNA or Exosomes,Zhang W,Yang L,Cell Physiol Biochem,SCI,2017-06,Zhejiang Provincial People’s Hospital,二区,5.5,755–768

---

8、IGF2BP2 promotes colorectal cancer cell proliferation and survival through interfering with RAF-1 degradation by miR-195,Ye S,Yang L,FEBS Lett,SCI,2016-06,Zhejiang University School of Medicine,三区,2.675,1641-50

---

9、Deep sequencing reveals the molecular pathology characteristics between primary uterine leiomyoma and pulmonary benign metastasizing leiomyoma,Jiang J,Yang L,Clin Transl Oncol,SCI,2018-08,Zhejiang Provincial People’s Hospital,三区,2.441,1080-1086

---

10、The effect of aspirin on circulating tumor cells in metastatic colorectal and breast cancer patients: a phase II trial study,Yang L, Ni C,Clin Transl Oncol,SCI,2018-07,Zhejiang Provincial People’s Hospital,三区,2.441,912-921

---

11、Aspirin to inhibit the formation and EMT of circulating tumor cells in patients with metastatic colorectal cancer but not breast cancer,Chao Ni,Yang L,J Clin Oncol,SCI,2017-06,Zhejiang Provincial People’s Hospital,一区, 28.245,e23024

---

12、Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma,Yang L,Huang J,J Cancer,SCI,2018-12,Zhejiang Provincial People’s Hospital,三区,3.182,3225-3235

---

13、Prospects of Noncoding RNAs in Hepatocellular Carcinoma,Zhou H,Yang L,Biomed Res Int,SCI,2018-07,Zhejiang Provincial People’s Hospital,三区,2.197,**

---

14、A Systematic Review of Long Noncoding RNAs in Hepatocellular Carcinoma: Molecular Mechanism and Clinical Implications,Hu X,Yang L,Biomed Res Int,SCI,2018-09,Zhejiang Provincial People’s Hospital,三区,2.197,**

---

15、The tumor suppressive miR-302c-3p inhibits migration and invasion of hepatocellular carcinoma cells by targeting TRAF4,Yang L,Xu Q, J Cancer,SCI,2018-06,Zhejiang Provincial People’s Hospital,三区,3.182,2693-2701

---

16、Mutation profiling of cancer and stromal cells from patients with pancreatic ductal adenocarcinoma,Yang L,Dongsheng Huang,J Clin Oncol,SCI,2018-06,Zhejiang Provincial People’s Hospital,一区,28.245,e16238

---

17、KLF4 p.A472D mutation: An acquired resistant mutation to cetuximab in colorectal cancer,Yang L,Dongsheng Huang,J Clin Oncol,SCI,2019-02,Zhejiang Provincial People’s Hospital,一区,28.245,e15077

---

18、Acidosis promotes tumorigenesis by activating AKT/NF-κB signaling,Yang L,Mo YY,Cancer Metastasis Rev,SCI,2019-02,Zhejiang Provincial People’s Hospital,二区,6.667,09785-6

---

19、Immunotherapy in pancreatic cancer: New hope or mission impossible,Jiang J,Yang L,Cancer Lett,SCI,2019-05,Zhejiang Provincial People’s Hospital,二区,6.508,57-64

---

20、lncRNA RMST Enhances DNMT3 Expression through Interaction with HuR,Peng WX,Yang L,Mol Ther,SCI,2019-10,Zhejiang Provincial People’s Hospital,二区,8.402,30453-8

---

21、LINC00346 promotes pancreatic cancer progression through the CTCF-mediated Myc transcription,Peng WX,Yang L,Oncogene,SCI,2019-08,Zhejiang Provincial People’s Hospital,二区,6.634,6770-6780

---

22、HBV Integration-mediated Cell Apoptosis in HepG2.2.15,Hu X,Yang L,J Cancer,SCI,2019-07,Zhejiang Provincial People’s Hospital,三区,3.182,4142-4150

---

23、A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis ,Yang L,Kangsheng Tu,Mol Cancer,SCI,2019-10,Zhejiang Provincial People’s Hospital,二区,10.679,28

---

科研项目
1、IGF2BP2-LncRNA DANCR-Lin28B Axis促进胰腺癌干细胞特性的分子机制研究,杨柳,浙江省人民医院,国家自然科学基金,国家级,2018-01,2020-12,50,50

---

2、Lnc-DC促进乳腺癌细胞他莫昔芬耐药的机制及临床研究,杨柳,浙江省人民医院,国家卫生计生委,省级,2018-01,2020-12,15,15

---

3、RAS野生型肠癌西妥昔单抗耐药靶点的筛选及靶向治疗的应用研究,杨柳,浙江省人民医院,浙江省科技厅,省级,2016-01,2018-12,15,15

---

4、酸性微环境LncRNA MALAT1介导NF-κB信号通路促进乳腺癌侵袭转移的作用机制研究 ,杨柳,浙江省人民医院,国家自然科学基金,国家级,2019-01,2023-12,55,55

---

科研成果
1、浙江省科学技术进步奖二等奖,杨柳,2,浙江省人民医院,浙江省人民政府,省级,2016-11

---

2、浙江省医药卫生科技奖一等奖,杨柳,2,浙江省人民医院,浙江省卫计委,省级,2016-04

---

个人信息